Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and…

Overview of attention for article published in Frontiers in oncology, November 2019

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 26 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 26 publications that cite this research output.

26

The most recent citing publications are shown below. View all 26 publications that cite this research output on Dimensions.

Induction-concurrent chemoradiotherapy with or without sintilimab in patients with locoregionally advanced nasopharyngeal carcinoma in China (CONTINUUM): a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial

Article in The Lancet (May 2024)

The efficacy of induction chemotherapy or adjuvant chemotherapy added to concurrent chemoradiotherapy in T3-4N0-1M0 nasopharyngeal carcinoma: a propensity score-matched analysis

Article in Cancer Biology & Therapy (November 2023)

A Novel Prognostic Model Predicts Outcomes in Non-Metastatic Nasopharyngeal Carcinoma Based on Inflammation, Nutrition, and Coagulation Signature

Article in Journal of Inflammation Research (November 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.